Miliary tuberculosis diagnosed by diffuse hepatic uptake on PET/CT and transjugular liver biopsy

Jeong YJ, Sohn MH, Lim ST, et al. ‘Hot liver’ on 18F-FDG PET/CT imaging in a patient with hepatosplenic tuberculosis. Eur J Nucl Med Mol Imaging. 2010;37:1618–9.

Article  PubMed  Google Scholar 

Wong SS, Yuen HY, Ahuja AT. Hepatic tuberculosis: a rare cause of fluorodeoxyglucose hepatic superscan with background suppression on positron emission tomography. Singap Med J. 2014;55:101–3.

Article  Google Scholar 

Vijayakumary B, Ramachandran C, Bharath VM, et al. Hot liver on 18F-FDG PET/CT imaging—a quandary for oncoradiologists in South Asia. BJR Case Rep. 2020;6:20190097.

Google Scholar 

Hickey JA, Gounder L, Drain KP. A systematic review of hepatic tuberculosis with considerations in human immunodeficiency virus co-infection. BMC Infect Dis. 2015;15:209.

Article  PubMed  PubMed Central  Google Scholar 

Hunt BJ, Andrews V, Pettingale KW. The significance of pancytopenia in miliary tuberculosis. Postgrad Med J. 1987;63:801–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klatskin G. Hepatic granuloma problems in interpretation. Ann N Y Acad Sci. 1976;278:427–32.

Article  CAS  PubMed  Google Scholar 

Diaz ML, Herrera T, Lopez-Vidal Y, et al. Polymerase chain reaction for the detection of Mycobacterium tuberculosis DNA in tissue and assessment of its utility in the diagnosis of hepatic granulomas. J Lab Clin Med. 1996;127:359–63.

Article  CAS  PubMed  Google Scholar 

Ravn P, Munk ME, Andersen AB, et al. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin Diagn Lab Immunol. 2005;12:491–6.

CAS  PubMed  PubMed Central  Google Scholar 

Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016;63:147–95.

Article  Google Scholar 

Dotter CT. Catheter biopsy. Experimental technic for transvenous liver biopsy. Radiology. 1964;82:312–4.

Article  CAS  PubMed  Google Scholar 

Hanafee W, Weiner M. Transjugular percutaneous cholangiography. Radiology. 1967;88:35–9.

Article  CAS  PubMed  Google Scholar 

Ishikawa T, Kamimura H, Tsuchiya A, et al. Comparison of a new aspiration needle device and the Quick-Core biopsy needle for transjugular liver biopsy. World J Gastroenterol. 2006;12:6339–42.

Article  PubMed  PubMed Central  Google Scholar 

Sugihara T, Koda M, Okamoto T, et al. The efficacy of transjugular liver biopsy (TJLB); a retrospective analysis. Kanzo. 2016;57:280–6.

Article  Google Scholar 

Kalambokis G, Manousou P, Vibhakorn S, et al. Transjugular liver biopsy—indications, adequacy, quality of specimens, and complications—a systematic review. J Hepatol. 2007;47:284–94.

Article  PubMed  Google Scholar 

Behrens G, Ferral H. Transjugular liver biopsy. Semin Intervent Radiol. 2012;29:111–7.

Article  PubMed  PubMed Central  Google Scholar 

Atar E, Ben Ari Z, Bachar GN, et al. A comparison of transjugular and plugged-percutaneous liver biopsy in patients with contraindications to ordinary percutaneous liver biopsy and an “in-house” protocol for selecting the procedure of choice. Cardiovasc Intervent Radiol. 2010;33:560–4.

Article  PubMed  Google Scholar 

Beckmann MG, Bahr MJ, Hadem J, et al. Clinical relevance of transjugular liver biopsy in comparison with percutaneous and laparoscopic liver biopsy. Gastroenterol Res Pract. 2009;2009: 947014.

Article  PubMed  PubMed Central  Google Scholar 

Tajima T, Noguchi T, Shida Y, et al. Transjugular liver biopsy using heart biopsy forceps: feasibility, complications and outcomes. JSIR & ISIR 2018 (programs and abstracts): 280

Dohan A, Guerrache Y, Dautry R, et al. Major complications due to transjugular liver biopsy: incidence, management and outcome. Diagn Interv Imaging. 2015;96:571–7.

Article  CAS  PubMed  Google Scholar 

Basu S, Nair N. Unusually elevated liver radioactivity on F-18 FDG PET in Hodgkin’s disease. Clin Nucl Med. 2004;29:626–8.

Article  PubMed  Google Scholar 

Tichelaar V, Gemmel F, de Rhoter W, et al. FDG hepatic superscan caused by massive breast cancer invasion. Clin Nucl Med. 2009;34:716–8.

Article  PubMed  Google Scholar 

Kaneko K, Nishie A, Arima F, et al. A case of diffuse-type primary hepatic lymphoma mimicking diffuse hepatocellular carcinoma. Ann Nucl Med. 2011;25:303–7.

Article  PubMed  Google Scholar 

Mahajan S, Kalra S, Chawla M, Dougall P. Detection of diffuse infiltrative primary hepatic lymphoma on FDG PET–CT: hallmarks of hepatic superscan. World J Nucl Med. 2016;15:142–4.

Article  PubMed  PubMed Central  Google Scholar 

Yang G, Nie P, Wang Z, et al. 18F-FDG hepatic superscan caused by a non-germinal center subtype of diffuse large B-cell lymphoma. Eur J Nucl Med Mol Imaging. 2016;43:1928.

Article  PubMed  Google Scholar 

Nonokuma M, Kuwabara Y, Takano K, et al. Evaluation of regional cerebral glucose metabolism in patients with malignant lymphoma of the body using statistical image analysis. Ann Nucl Med. 2014;28:950–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif